
Trust Signals
Key Takeaways
- A seizure letter means your parcel was intercepted and forfeited. No fine is automatically attached; it is an administrative notification under the Customs Act 1901.
- An infringement notice (fine) is a separate enforcement action, issued at officer discretion, and is more likely when quantities exceed a plausible personal-use amount or when there is a prior interception record.
- Most research peptides, including BPC-157, TB-500, CJC-1295, and melanotan analogues, are prescription-only or prohibited imports in Australia without a TGA import permit. The personal importation scheme does not apply to them.
- Paying an infringement notice is not a formal criminal conviction under Australian law, but ABF and TGA retain internal records of interceptions that affect future risk profiling.
- Criminal prosecution for personal-quantity first-time imports is rare in practice, but the legal maximum penalties under the Therapeutic Goods Act 1989 and the Customs Act 1901 are serious and include imprisonment for commercial-scale violations.
Direct Answer: Seizure Letter vs Fine for Australian Peptide Imports
A seizure letter is an administrative notice that your goods have been taken; no money is owed and no conviction results. A fine (infringement notice) is an additional enforcement step issued separately at officer discretion, more common for repeat importers or larger quantities. Most first-time personal-quantity interceptions end with the letter only, and the goods are destroyed or forfeited.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of Contents
- What law governs peptide imports in Australia?
- What is a seizure letter and what does it mean?
- What is an infringement notice (fine) and when is one issued?
- Evidence ledger: what we know and how confident we are
- What does ABF actually look for when screening packages?
- What most import guides get wrong
- Seizure letter vs fine: honest head-to-head comparison
- What to do if you receive a seizure letter or fine
- Operational literacy: reading your notice and understanding your options
- FAQ
- Sources
- Disclaimers
What Law Governs Peptide Imports in Australia?
Three main instruments control this area. First, the Therapeutic Goods Act 1989 (Cth) regulates the importation of therapeutic goods. Most synthetic peptides sold as research compounds are captured as therapeutic goods because they are designed to affect physiological processes in humans or animals. Importing them without inclusion on the Australian Register of Therapeutic Goods (ARTG) or a valid import approval is an offence.
Second, the Customs (Prohibited Imports) Regulations 1956 designate specific categories of goods, including Schedule 4 (prescription-only) substances, as prohibited imports unless a relevant permit or approval is held. Peptides that are schedule medicines, such as growth hormone secretagogues classified under Schedule 4 of the Poisons Standard, fall into this category.
Third, the Customs Act 1901 (Cth) provides ABF's powers to detain, examine, seize, and forfeit goods, and to issue notices of seizure. It also creates offences for importing prohibited goods, with penalties scaled to commercial or personal intent.
What Is a Seizure Letter and What Does It Mean?
Under section 205 and related provisions of the Customs Act 1901, when ABF seizes goods, the importer must be notified. In practice, you receive a written notice, commonly called a seizure letter, that states the goods have been seized, identifies the legislative provision relied upon, and explains your right to claim the goods or contest the seizure within a specified timeframe (commonly 30 days, though this varies by circumstance).
For most peptide recipients, the seizure letter is the end of active contact with ABF. You do not need to pay anything. The goods are not delivered. ABF or TGA will arrange destruction of the substances. No criminal record is created by the letter itself. The letter is, however, an internal record of an interception event linked to your name and address.
You have the right to contest the seizure if you believe the seizure was unlawful or you have a legitimate import permit. For research peptides imported without a permit, a contest is almost never successful.
What Is an Infringement Notice (Fine) and When Is One Issued?
An infringement notice is a separate document from a seizure letter. It is issued under infringement notice provisions in the Regulatory Powers (Standard Provisions) Act 2014, or under specific provisions in the Therapeutic Goods Act 1989, and allows an authorised officer to issue a penalty in lieu of pursuing criminal prosecution.
Key characteristics of infringement notices in this context:
- The penalty amount is typically a fraction of the maximum court-imposed fine (often one-fifth of the maximum penalty unit for the relevant offence, though exact figures depend on the specific provision and are set by legislation).
- Payment is voluntary in the sense that you can decline to pay and elect to have the matter heard in court instead, though this carries greater legal risk and cost.
- Paying does not create a formal criminal conviction but does not immunise against future prosecution if the conduct is later found to be more serious.
- Officers exercise discretion. Factors that increase the likelihood of an infringement notice include: quantity exceeding obvious personal use, repeat interception history, commercial packaging or labelling, or concurrent interception of multiple controlled substances.
For typical single-parcel personal-quantity imports, infringement notices are less common than seizure letters alone, based on publicly reported TGA and ABF compliance activity. Exact infringement notice issuance rates for peptide imports are not publicly reported in disaggregated form.
Evidence Ledger: What We Know and How Confident We Are
| Claim | Best evidence type | Direction | Confidence |
|---|---|---|---|
| Most research peptides are prohibited imports without a TGA permit | Statutory text (Therapeutic Goods Act 1989, Customs (Prohibited Imports) Regulations 1956, Poisons Standard) | Confirmed | High |
| Seizure letter does not itself create a criminal record | Statutory text (Customs Act 1901 s.205 and related); established criminal law principle | Confirmed | High |
| Infringement notice payment is not a criminal conviction under Australian law | Regulatory Powers (Standard Provisions) Act 2014, s.103; established legal principle | Confirmed | High |
| Criminal prosecution for personal-quantity first-time peptide imports is rare | TGA annual compliance reports (published narratively, not as disaggregated peptide-specific data); practitioner accounts | Supported but not quantified | Moderate |
| ABF retains internal records of interceptions that affect future risk profiling | ABF published guidance on border targeting; consistent with intelligence-led targeting frameworks | Supported | Moderate |
| Growth hormone secretagogue peptides are among the most commonly intercepted classes | TGA compliance reports (publicly available, noting GHS and performance-enhancing peptides as enforcement priorities) | Confirmed directionally | Moderate |
| Specific infringement notice issuance rates for peptide imports | No publicly available disaggregated data found | Unknown | Very Low (no data) |
What Does ABF Actually Look for When Screening Packages?
ABF operates a risk-based targeting system at major clearance facilities including Sydney, Melbourne, and Brisbane. Published ABF guidance and TGA enforcement strategies indicate the following factors attract scrutiny:
- Country of origin: Shipments from countries with known peptide manufacturing or supply hubs attract higher inspection rates based on intelligence-led profiling.
- Misdescription on customs declarations: Labelling a vial of lyophilised peptide as "cosmetic," "laboratory standard," or using vague category descriptions is a known interception trigger. ABF officers are trained to identify packaging inconsistencies.
- Declared value anomalies: Under-declaring value to avoid customs duties flags a parcel for closer examination.
- Recipient history: If your address or name has had a prior interception, the risk of future interceptions being actioned more seriously increases. ABF shares interception data with TGA.
- Quantity and packaging: Multiple vials, commercial-scale quantities, or packaging consistent with resale rather than personal use all elevate enforcement response.
X-ray scanning at mail centres can identify vials and unusual dense objects. Chemical testing occurs for substances that clear visual screening but remain suspect. ABF does not publicly disclose its detection algorithms.
What Most Import Guides Get Wrong
The majority of forum posts and peptide vendor FAQs circulating about Australian import risk contain at least one of the following material errors:
1. Conflating the personal importation scheme with research peptides. The TGA personal importation scheme does allow individuals to import certain unapproved therapeutic goods for personal use. However, the scheme requires that the product be a genuine therapeutic product for your own medical condition, and most research peptides are not eligible because they are not approved in Australia or in their country of export as a medicine, and they lack a prescribing doctor in many cases. Vendors who cite "personal importation" as a legal cover for research peptide imports are misleading their customers.
2. Claiming that a seizure letter "means nothing" legally. The letter itself carries no fine and creates no criminal record. That much is accurate. But it does create an ABF and TGA record. A second or third interception is treated materially differently from a first. Guides that tell users to simply "ignore the letter and reorder" understate cumulative legal risk.
3. Overstating how vague the legal category of "research peptides" is. The argument that a substance is a "research chemical" and therefore not a therapeutic good has been tested and generally rejected in Australian enforcement practice. The Therapeutic Goods Act 1989 definition of a therapeutic good is broad and function-based, not label-based. If a substance is intended to affect physiological processes in humans, it is captured regardless of what the label says.
4. Misrepresenting stealth packaging as a reliable protection. Vendors who ship peptides in misleadingly labelled packaging are committing an offence under Australian customs law and potentially under the criminal code. The importer who accepts such goods is not necessarily shielded from liability merely because the vendor mislabelled the package. Mislabelling can actually worsen the legal position if it demonstrates knowledge of the prohibited nature of the goods.
Seizure Letter vs Fine: Honest Head-to-Head Comparison
| Factor | Seizure Letter Only | Infringement Notice (Fine) | Criminal Prosecution |
|---|---|---|---|
| Financial cost | None directly (loss of goods and purchase cost) | Penalty amount set by legislation, typically in hundreds to low thousands AUD | Court fines potentially far higher; legal costs additional |
| Criminal record created? | No | No, if paid (not a conviction) | Yes, if convicted |
| ABF/TGA internal record created? | Yes | Yes | Yes |
| Response required? | Not legally required | Must pay or elect court within timeframe | Legal representation strongly advised |
| Typical trigger | First-time, personal quantity | Repeat interception, higher quantity, or officer discretion | Commercial quantity, repeat serious offending, or additional aggravating factors |
| Likelihood for personal-quantity first import | Most common outcome | Less common but possible | Rare for personal use; real for commercial scale |
| Can you contest it? | Yes (contest seizure within 30 days; rarely successful without a permit) | Yes (elect court instead of paying) | Full criminal defence available |
What to Do If You Receive a Seizure Letter or Fine
If you receive a seizure letter only: Read it carefully. Note any deadline for contesting the seizure. If you had no import permit and the goods were research peptides, contesting is unlikely to succeed. You are not required to respond. Do not voluntarily contact ABF to explain or apologise without legal advice, as any written or verbal statement can be used. If no further correspondence arrives within several weeks, the matter is likely administratively closed for now.
If you receive an infringement notice: Note the payment deadline carefully. You have the option to pay the penalty (which is not an admission of guilt and not a conviction) or to elect to have the matter heard in court. Electing court carries greater uncertainty and cost but may be appropriate if the notice is factually incorrect or the amount is disproportionate. Consult a lawyer before deciding, particularly if the amount is significant or circumstances are complex.
If you receive a summons or notice to appear in court: This is a criminal matter. Engage an Australian criminal defence lawyer with customs or regulatory experience immediately. Do not respond to investigators without legal representation.
Operational Literacy: Reading Your Notice and Understanding Your Options
A genuine ABF or TGA notice will include: the name of the seizing officer and their authority, the specific legislative provision under which the goods were seized, a description of the goods, a reference number, and instructions for any response or appeal. If you receive correspondence that lacks these elements, verify its authenticity directly with ABF or TGA using contact details from their official websites, not contact details in the letter itself.
Key things to check on a seizure letter:
- The section of the Customs Act 1901 cited (e.g., s.203 for seizure without warrant, s.205 for notice requirements). This tells you the type of seizure and your contestability window.
- Whether the letter references TGA as a co-regulator. TGA involvement signals the therapeutic goods angle is being pursued, not merely a customs valuation issue.
- The 30-day (or other specified) timeframe for lodging a claim for the goods. Missing this window forfeits your right to contest.
Key things to check on an infringement notice:
- The specific provision under which the penalty is issued. This determines whether it falls under the Therapeutic Goods Act 1989 or the Customs Act 1901, which affects your appeal pathway.
- The penalty amount and payment instructions, and the deadline for electing court instead.
- Whether the notice correctly identifies you and the goods. Errors in identification may be grounds to contest.
Do not: Attempt to import again using a different address immediately after a seizure. ABF and TGA share interception data, and patterns of repeated import attempts escalate enforcement response. Do not use return address manipulation or third-party reshipping services in an attempt to circumvent interception; these acts can themselves constitute additional offences.
FAQ
What is an Australia Border Force peptide seizure letter?
A seizure letter (formally a 'Notice of Seizure') is an official document issued under the Customs Act 1901 notifying you that ABF has detained or seized your imported goods. For peptides, this typically means the parcel was intercepted and will not be delivered. No financial penalty is attached to the letter itself, but it documents that a breach was detected.
What is an infringement notice (fine) from ABF for peptides?
An infringement notice is a financial penalty issued under the Regulatory Powers (Standard Provisions) Act 2014 or specific customs or therapeutic goods legislation. For low-value personal import violations, fines are typically set at a fraction of the maximum court penalty, often in the hundreds to low thousands of AUD, and are issued at ABF or TGA officer discretion.
Do most peptide seizures in Australia result in a fine?
No. The most common outcome for a first-time personal-quantity peptide import is a seizure letter only, with the goods forfeited. Infringement notices and criminal referrals are less common for personal amounts and are more likely when quantities suggest commercial supply or when there is a repeat history.
Are research peptides like BPC-157 or TB-500 legal to import into Australia?
Most synthetic peptides sold as research compounds are either prescription-only medicines or prohibited imports under Australian law without a valid TGA import permit. BPC-157 and TB-500 are not TGA-approved drugs and have no personal importation exemption. Importing them without a permit is a breach of the Customs (Prohibited Imports) Regulations 1956 and the Therapeutic Goods Act 1989.
Should I respond to a seizure letter?
You are not legally required to respond to a seizure letter, and responding without legal advice can create a written record that confirms your identity and intent. If you receive a letter and a separate formal notice requesting a response or interview, consult a customs or criminal lawyer before replying.
Can ABF prosecute me criminally for importing peptides?
Yes, criminal prosecution is possible under the Customs Act 1901 and the Therapeutic Goods Act 1989, with maximum penalties that can include imprisonment. In practice, criminal prosecution for small personal-use quantities is rare but not impossible, especially for repeat offenders or where the substance is classified as a Schedule 4 or higher drug.
What is the TGA personal importation scheme and does it cover peptides?
The TGA personal importation scheme allows individuals to import a three-month supply of certain therapeutic goods for personal use. However, the goods must be a registered or approved therapeutic product in Australia or in the country of origin, and must be for a genuine personal medical need. Most research peptides do not meet these criteria and are not covered.
What does ABF look for when screening peptide packages?
ABF uses X-ray scanning, physical inspection, and intelligence targeting at major mail and air cargo centres. Packages are more likely to be intercepted when labelled ambiguously (e.g., 'research chemical' or 'cosmetic'), shipped from known source countries, declared with low or inaccurate values, or when the recipient has a prior interception history.
If I receive a seizure letter, will it appear on a criminal record?
A seizure letter alone does not create a criminal record. A criminal record only results from a successful prosecution in court. An infringement notice, if paid, is also generally not a criminal conviction. However, ABF and TGA maintain internal records of interceptions that can affect future import risk assessments.
How long does ABF have to issue a fine or commence prosecution after seizure?
Limitation periods vary by offence type. For summary offences under the Customs Act 1901, prosecution must generally commence within a period defined by the relevant limitation provisions. Infringement notices are typically issued closer to the time of interception. Consult a lawyer if significant time has passed and you have not received any follow-up correspondence.
Does paying an infringement notice mean I am admitting guilt?
Under Australian infringement notice schemes, paying the penalty is not a formal admission of guilt and does not result in a conviction. However, it does not extinguish all potential liability if the conduct was serious enough for separate criminal proceedings. Legal advice is recommended before paying if the amount is large or the circumstances are complex.
What peptides are most commonly seized at the Australian border?
TGA compliance reports (publicly available) identify growth hormone secretagogues (such as CJC-1295, Ipamorelin, GHRP-2, GHRP-6), BPC-157, TB-500, and melanotan peptides as commonly intercepted classes. These substances are prescription-only or prohibited imports without a valid permit.
Sources
- Customs Act 1901 (Cth). Federal Register of Legislation. legislation.gov.au
- Therapeutic Goods Act 1989 (Cth). Federal Register of Legislation. legislation.gov.au
- Customs (Prohibited Imports) Regulations 1956 (Cth). Federal Register of Legislation. legislation.gov.au
- Regulatory Powers (Standard Provisions) Act 2014 (Cth), Part 5 (Infringement notices). Federal Register of Legislation. legislation.gov.au
- Therapeutic Goods Administration. Annual Performance Statements and Compliance Reports. Australian Government Department of Health. tga.gov.au
- Australian Border Force. Travellers and goods: prohibited and restricted goods. abf.gov.au
- Therapeutic Goods Administration. Personal importation of medicines. tga.gov.au
- Poisons Standard 2015 (Cth) (as amended). Federal Register of Legislation. legislation.gov.au
- Therapeutic Goods Administration. Regulation of peptides and performance-enhancing substances. TGA enforcement priorities guidance. tga.gov.au
- Australian Border Force. Goods seizure and notice procedures. ABF Operational Guidelines (publicly available sections). abf.gov.au